LifeStance Health Group Financial Statements (LFST)
|
|
|
|
Report date
|
|
|
31.12.2020 |
17.03.2022 |
31.12.2022 |
09.03.2023 |
31.12.2023 |
|
07.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
377.2 |
667.5 |
859.5 |
859.5 |
1 056 |
|
1 206 |
|
Operating Income, bln rub |
|
|
15.4 |
-286.4 |
-210.2 |
-210.2 |
-189.1 |
|
-63.5 |
|
EBITDA, bln rub |
? |
|
8.77 |
-229.6 |
-109.3 |
-136.4 |
-104.9 |
|
14.1 |
|
Net profit, bln rub |
? |
|
-38.1 |
-307.2 |
-215.6 |
-215.6 |
-186.3 |
|
-95.3 |
|
|
OCF, bln rub |
? |
|
-8.53 |
9.42 |
52.8 |
52.8 |
-16.9 |
|
61.7 |
|
CAPEX, bln rub |
? |
|
38.1 |
94.5 |
79.3 |
79.3 |
40.5 |
|
26.7 |
|
FCF, bln rub |
? |
|
-46.6 |
-85.1 |
-26.5 |
-26.5 |
-57.4 |
|
35.1 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
330.7 |
487.9 |
1 070 |
447.2 |
491.2 |
|
588.7 |
|
Cost of production, bln rub |
|
|
242.9 |
466.0 |
0.000 |
622.5 |
753.6 |
|
1 142 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
22.1 |
38.9 |
19.9 |
19.9 |
21.2 |
|
22.7 |
|
|
Assets, bln rub |
|
|
1 570 |
1 927 |
2 174 |
2 174 |
2 233 |
|
2 108 |
|
Net Assets, bln rub |
? |
|
997.8 |
1 545 |
1 519 |
1 519 |
1 429 |
|
1 437 |
|
Debt, bln rub |
|
|
362.5 |
157.4 |
476.5 |
476.5 |
511.0 |
|
486.7 |
|
Cash, bln rub |
|
|
18.8 |
148.0 |
108.6 |
108.6 |
78.8 |
|
102.6 |
|
Net debt, bln rub |
|
|
343.7 |
9.39 |
367.9 |
367.9 |
432.2 |
|
384.1 |
|
|
Ordinary share price, rub |
|
|
|
9.52 |
4.94 |
4.94 |
7.83 |
|
5.95 |
|
Number of ordinary shares, mln |
|
|
373.6 |
327.5 |
355.3 |
355.3 |
367.5 |
|
378.7 |
|
|
Market cap, bln rub |
|
|
0 |
3 118 |
1 755 |
1 755 |
2 877 |
|
2 253 |
|
EV, bln rub |
? |
|
344 |
3 127 |
2 123 |
2 123 |
3 309 |
|
2 637 |
|
Book value, bln rub |
|
|
-434 |
40 |
-18 |
-18 |
-85 |
|
-52 |
|
|
EPS, rub |
? |
|
-0.10 |
-0.94 |
-0.61 |
-0.61 |
-0.51 |
|
-0.25 |
|
FCF/share, rub |
|
|
-0.12 |
-0.26 |
-0.07 |
-0.07 |
-0.16 |
|
0.09 |
|
BV/share, rub |
|
|
-1.16 |
0.12 |
-0.05 |
-0.05 |
-0.23 |
|
-0.14 |
|
|
EBITDA margin, % |
? |
|
2.32% |
-34.4% |
-12.7% |
-15.9% |
-9.94% |
|
1.17% |
|
Net margin, % |
? |
|
-10.1% |
-46.0% |
-25.1% |
-25.1% |
-17.6% |
|
-7.90% |
|
FCF yield, % |
? |
|
|
-2.73% |
-1.51% |
-1.51% |
-2.00% |
|
1.56% |
|
ROE, % |
? |
|
-3.82% |
-19.9% |
-14.2% |
-14.2% |
-13.0% |
|
-6.63% |
|
ROA, % |
? |
|
-2.43% |
-15.9% |
-9.92% |
-9.92% |
-8.34% |
|
-4.52% |
|
|
P/E |
? |
|
0.00 |
-10.1 |
-8.14 |
-8.14 |
-15.4 |
|
-23.6 |
|
P/FCF |
|
|
0.00 |
-36.7 |
-66.3 |
-66.3 |
-50.1 |
|
64.3 |
|
P/S |
? |
|
0.00 |
4.67 |
2.04 |
2.04 |
2.73 |
|
1.87 |
|
P/BV |
? |
|
0.00 |
77.7 |
-100.2 |
-100.2 |
-33.7 |
|
-43.7 |
|
EV/EBITDA |
? |
|
39.2 |
-13.6 |
-19.4 |
-15.6 |
-31.5 |
|
186.9 |
|
Debt/EBITDA |
|
|
39.2 |
-0.04 |
-3.37 |
-2.70 |
-4.12 |
|
27.2 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
10.1% |
14.2% |
9.22% |
9.22% |
3.84% |
|
2.21% |
|
| LifeStance Health Group shareholders |
